Blade Air Mobility Inc BLDE reported first-quarter FY23 revenue growth of 70% year-over-year to $45.27 million, beating the consensus of $40.51 million.
- Passenger revenue grew 32.6% Y/Y to $18.5 million, and Medical revenue +111.2% Y/Y to $26.78 million.
- Flight profit rose to $7.16 million (+145.1% Y/Y), and the margin improved by 485 bps to 15.8%.
- Strong growth in BLDE's MediMobility Organ Transport business, Blade Canada, and contribution from Blade Europe acquisitions drove flight profit.
- Loss per share improved to $(0.14), from $(0.16) in 1Q22, beating the consensus of $(0.21).
- Loss from operations contracted to $(12.83) million, compared to $(13.69) million a year ago.
- Adjusted EBITDA loss was flat YoY at $(7.72) million, margin improved to (17.1%) from (29%) in 1Q22.
- Blade's net cash used in operating activities for the quarter totaled $(16.86) million, compared to $(10.07) million a year ago.
- The company held cash and cash equivalents of $41.74 million as of March 31, 2023.
- Blade continues to demonstrate the leverage of its air mobility platform as year-over-year Flight Profit growth significantly exceeded the growth rate in Revenue and Adjusted Corporate Expense, CFO Will Heyburn said.
- Price Action: BLDE shares are trading higher by 7.29% at $3.09 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in